The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, the dominant player in colorectal cancer screening, Evercore ISI analysts said.
Freenome, an early cancer detection company developing blood-based screening tests, today announced favorable results from its pivotal clinical validation study assessing the performance of assay and ...
Woman's World on MSN
Colon cancer screening guidelines changed: What women over 40 need to know
Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...
When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors who ...
Add Yahoo as a preferred source to see more of our stories on Google. The American Cancer Society (ACS) updated its guidelines Wednesday to include two new screening options for colorectal cancer, ...
People often dismiss rectal bleeding as a minor or embarrassing problem, but doctors say it should never be ignored because ...
Under the collab, Walgreens customers will be able to access tools and resources to better understand their colorectal cancer screening options. "As a trusted health partner in the community, we have ...
More cases of colorectal cancer are detected at an early stage with screening. This is according to new research based on data from over 278,000 60-year-olds, who were randomly selected to undergo one ...
He was diagnosed with Stage 3B colorectal cancer. The cancer had spread to two lymph nodes. He then underwent six months of ...
Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...
As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...
A study reveals significant disparities in cancer screening rates among sexual and gender minorities, highlighting the need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results